A Multicentre Randomized Double-Blind Placebo-Controlled Phase III Study of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-severe Plaque PsoriasisLin Cai,Congjun Jiang,Guoqiang Zhang,Hong Fang,Jinyan Wang,Yumei Li,Hui Xu,Rong Xiao,Yangfeng Ding,Kun Huang,Chunlei Zhang,Litao Zhang,Bin Chen, Xinsuo Duan,Weili Pan,Guangming Han,Rongyi Chen,Lunfei Liu,Shoumin Zhang,Juan Tao,Xiaowen Pang,Jianbin Yu,Huiping Wang,Yi Zhao,Chengxin Li,Xiaojing Kang,Lanying Qin, Xiaofang Zhu,Juan Su,Shanshan Li,Chunjun Yang,Wenli Feng,Tiechi Lei,Shan Jiang,Ruihua Fang,Mao Lin,Qianjin Lu,Chunxing Xu, Wei Wang,Jianzhong ZhangBritish Journal of Dermatology（2024）引用 2|浏览45AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
